{
  "trial_id": "NCT02156843",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Patients who have given voluntary written informed consent to participate in this study prior to conducting Screening (Visit 1) procedures;",
      "label": "met"
    },
    {
      "criterion": "Women of childbearing potential (WOCBP) who agree to use appropriate birth control (double-barrier methods, hormonal contraceptives, or intrauterine device) for the duration of the study",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with type 1 diabetes or MODY (a monogenic form of diabetes);",
      "label": "triggers"
    },
    {
      "criterion": "Patients who used SCr-altering drugs within 30 days prior to Visit 1;",
      "label": "triggers"
    }
  ],
  "notes": "The patient is a 3-day-old female infant with jaundice that started one day ago. She was born at 34w of gestation and kept in an incubator due to her gestational age.",
  "_meta": {
    "topic_id": "73",
    "trial_id": "NCT02156843",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}